期刊文献+

2002~2004年我院抗高血压药物使用情况分析 被引量:3

Analysis of application for antihypertensives in our hospital during the period 2002~2004
下载PDF
导出
摘要 目的:了解我院2002~2004年抗高血压药物的使用状况和发展趋势并进行用药合理性的评估与分析.方法:对2002~2004年期间消耗的抗高血压药物的销售金额、用药频度及日均费用的变化进行排序、分类汇总等统计分析.结果:我院抗高血压药物的用药频度和销售金额逐年增长,排在前3位的是钙拮抗剂、血管紧张素转换酶抑制剂和β受体阻滞剂.用药频度前10位的主要是降压效果肯定而价格相对低廉的品种;销售金额前10位的主要是上市不久、价格昂贵的新品种.结论:我院抗高血压药物的应用状况基本合理. Objective: To investigate the application situation and tendency of antihypertensives in our hospital during the period 2002-2004 and evaluate rationality. Methods: The sum of consumption, DDDs and daily cost of antihypertensives consumed during the past three years were analyzed. Results: The sum of consumption, DDDs of antihypertensives consumed increased year after year, and calcium antagonists, ACEI and β-receptor antagonist were three leading types. The ten leading drugs of DDDs were mainly effective and cheap, and the leading drugs of the sum of consumption were mainly new and expensive. Conclusion: The application of antihypertensives is basically reasonable in our hospital.
出处 《华夏医学》 2005年第6期926-928,共3页 Acta Medicinae Sinica
关键词 抗高血压药物 用药频度 约定日剂量 antihypertenstves DDDs detmed dally dose
  • 相关文献

参考文献3

二级参考文献21

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 2黄震华,徐济民.血管紧张素Ⅱ受体及其拮抗剂[J].新药与临床,1995,14(6):366-368. 被引量:28
  • 3吴兆苏,姚崇华,赵冬,吴桂贤,王薇,刘静,曾哲淳,吴英恺.我国多省市心血管病趋势及决定因素的人群监测(中国MONICA方案)Ⅰ.发病率和死亡率监测结果[J].中华心血管病杂志,1997,25(1):6-11. 被引量:205
  • 4金良彪.北京地区抗高血压药概述[J].中国医药荟萃,1995,6(1):7-7.
  • 5Franz HM. Reinhard K. Left ventricular hypertrophy, a pressure independent cardiovascular risk factor, j cardiovasc pharmacol, 1993,22(suppl 1):713.
  • 6Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventrleular hypertrophy comparison to necropsy findings. Am J Cardiol, 1986,57:450-454.
  • 7Pahor M, Bernibei R, Sgidari A, et al. Enalapril prevents cardiac fibrosis and arrhythmias in hypertensive rats. Hypertension, 1991, 18:148.
  • 8Hua L, Li C, Xia D, et al. Relationship between hypertensive left ventricular hypertrophy and levels of endothelin and nitric oxide. Hypertens Res, 2000,23 : 377-380.
  • 9Kamide K, Nagano M, Nakano N, et al. Insulin resistance and cardiovascular complications in patients with essential hypertension. Am J Hyperten,1996,9:1165-1171.
  • 10孙大宁.血管紧张素Ⅱ受体拮抗剂销售势头看好[J].药学进展,1998,22(3):184-184.

共引文献43

同被引文献13

引证文献3

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部